Ocular adnexal lymphomas: a review (Record no. 76362)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02325cam a2200217 4500 |
| 001 - CONTROL NUMBER | |
| control field | NMDX7477 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120401t2017 xxu||||| |||| 00| 0 eng d |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Richards, H. |
| 240 ## - UNIFORM TITLE | |
| Uniform title | <a href="Expert Review of Ophthalmology">Expert Review of Ophthalmology</a> |
| 245 ## - TITLE STATEMENT | |
| Title | Ocular adnexal lymphomas: a review |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | 2017 |
| 500 ## - GENERAL NOTE | |
| General note | NMUH Staff Publications |
| 500 ## - GENERAL NOTE | |
| General note | EMBASE |
| 500 ## - GENERAL NOTE | |
| General note | 12 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | <span style="font-size: 10pt;"><span style="color: #4a4a4a; font-family: Lato, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; text-decoration-color: initial;">Introduction: Lymphoma is the commonest malignancy of the ocular adnexa. Its relatively low incidence and significant heterogeneity pose unique clinical, diagnostic and therapeutic challenges, requiring a multidisciplinary approach to its management. We present an overview of the literature regarding the epidemiological and clinico-pathological features of ocular adnexal lymphoma (OAL), current staging methods and therapeutic approaches. Areas covered: We searched MEDLINE for publications on OALs from 1990 to the present day and conducted a manual search of the reference sections of relevant articles and book chapters. Radiotherapy and chemo-immunotherapy are widely used current treatment options in the most common subtypes of OAL and generally offer excellent long-term outcomes. We discuss the emerging role of anti-microbial therapy in marginal zone lymphoma associated with Chlamydia psittaci, the prevalence of which shows significant geographical variation. Several novel and targeted therapeutic agents have emerged in the setting of relapsed and refractory B-cell non-Hodgkin lymphomas, and are likely to become future treatment options in OALs. Expert commentary: The recognition of new pathways and prognostic molecular markers in lymphomas is also expected to result in better prognostication, novel therapeutic targets and personalised therapies in OAL. It is important that multi-center collaborative approaches are pursued for continued progress in the field.</span>&nbsp;</span> |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Naidoo, R. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jacob, E. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohamedbhai, S. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://www.tandfonline.com/doi/full/10.1080/17469899.2017.1280394">http://www.tandfonline.com/doi/full/10.1080/17469899.2017.1280394</a> |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://ferriman.wufoo.com/forms/journal-article-request/">http://ferriman.wufoo.com/forms/journal-article-request/</a> |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Staff publications for NMDX | Ferriman information and Library Service (North Middlesex) | Ferriman information and Library Service (North Middlesex) | Shelves | 07/06/2022 | 07/06/2022 | 07/06/2022 | Book |